compound semaglutide fda approved Ends Compounded GLP-1s: What to Know Compounded "semaglutide" is not FDA-approved

So far, Semaglutide has shown limited efficacy in controlling blood sugar levels and promoting weight loss in a small population of type 2 diabetes patients

Dehydration worsens every GI side effect

Ongoing Research and Development Research continues to expand potential applications for bremelanotide beyond the approved indication: Phase 2 Trial for Male ED (Initiated June 2024): Palatin Technologies launched an open-label, dose-escalation study enrolling approximately 50 men with erectile dysfunction unresponsive to PDE5 inhibitor monotherapy

After the initial month, the dosing increases to 7 mg daily for at least another four weeks

ME-S: Resources, Writing original draft, Software, Methodology, Writing review & editing

Semaglutide is not a controlled substance, so the federal restrictions specific to remote prescribing of controlled medications do not apply